Yen-Chen Liu

Title: Yen-Chen Liu: Innovator in Inflammatory Pain Treatment

Introduction

Yen-Chen Liu is a prominent inventor based in Tainan, Taiwan, known for his significant contributions to biomedical research. With a keen focus on pain management, Liu has developed innovative approaches to treating conditions associated with inflammatory pain.

Latest Patents

Liu holds one patent titled "Treatment of inflammatory pain using IL-20 antagonists." This patent addresses methods for reducing inflammatory pain in individuals suspected of suffering from such conditions. The invention involves the use of IL-20 antagonists, which can include antibodies designed to block the signaling pathways mediated by IL-20. Notably, these antibodies include both anti-IL-20 antibodies and anti-IL-20R antibodies that specifically interrupt the IL-20 signaling pathway, showcasing a promising avenue for therapeutic intervention.

Career Highlights

Currently, Yen-Chen Liu is affiliated with National Cheng Kung University, where his research continues to influence the field of pain management. His work emphasizes innovative techniques that leverage the body's biological mechanisms to mitigate distress caused by inflammation.

Collaborations

In his collaborative efforts, Liu works alongside esteemed colleagues such as Ming-Shi Chang and Meng-Ru Shen. Their combined expertise contributes to more comprehensive research projects, enhancing the potential impact of their findings in the medical community.

Conclusion

Yen-Chen Liu stands out as an innovator in the field of biomedical research, particularly in the treatment of inflammatory pain. Through his patent and collaborative efforts with talented peers, he is making strides towards effective pain management solutions that may benefit countless individuals affected by inflammatory conditions.